Leadership

These individuals guide the overall strategy, governance, and operations of A5.

Executive Chair

Current Chair

The Executive Chair leads A5 with a commitment to advancing adrenal tumor research through global collaboration and innovation. Serving as the primary spokesperson and strategic guide, the Chair works closely with the leadership team and members to shape the organization’s vision, foster partnerships, and drive impactful initiatives.

Mouhammed Amir Habra, MD
2024-Present

The University of Texas MD Anderson Cancer Center, USA

Honoring our leadership legacy

Past Chairs

Organization is grateful for the governance provided by the previous chairs.

Lauren Fishbein, MD, PhD
2022-2024

University of Colorado, USA

Driving focus and collaboration

Working Group Leads

Our working groups unite experts focused on specialized areas of adrenal tumor research, fostering collaboration across institutions and disciplines. Through shared projects and data, they drive innovation and accelerate the translation of discoveries into clinical practice.

Adrenocortical carcinoma

Katja Kiseljak-Vassiliades
2024-2026

University of Colorado, USA

Hiro Sasano, MD, PhD
2024-2026

Tohoku University, Japan

Primary aldosteronism

Jun Yang, MBBS, FRACP, PhD
2024-2026

Hudson-Institution of Medical Research, Australia

Pratibha Rao, MD
2024-2026

Cleveland Clinic, USA

Pheochromocytoma and paraganglioma

Rory Clifton-Bligh, PhD
2024-2026

University of Sydney, Australia

Madson Queiroz De Almedia, MD
2024-2026

University of São Paulo, Brazil

Benign adrenal lesions (non-APA)

Irina Bancos, MD
2024-2026

Mayo Clinic, USA

Jung Hee Kim, MD
2024-2026

Seoul National University, South Korea

Become a Member

Join A5

A5 is a growing organization  made up of clinicians, researchers, trainees, students, and advocates from more than 50 major academic and research centers in the three continents. Support adrenal research and become part of a growing global network!